Revolutionary Saliva Test Validated for Endometriosis – Femtech Insider
Femtech Insider shared a post on LinkedIn:
“NEJM Evidence has published a validation study for Ziwig Biotech Endotest, a saliva-based diagnostic test for endometriosis. The study reports results from a prospective, independent, multicenter clinical trial conducted across 17 public and private hospitals in France.
The study reported sensitivity of 97.3%, specificity of 94.1%, overall accuracy of 96.6%, positive predictive value of 98.2%, and negative predictive value of 91.3%. Performance remained consistent across all subgroups, regardless of hormonal treatment, analgesic use, inclusion site, or sequencing conditions.
‘This publication in NEJM Evidence is a major step forward for science and for women affected by endometriosis. We are deeply grateful to all the women, hospitals, and healthcare professionals whose commitment and support have been essential in bringing this innovation to patients.’ Yahya EL MIR, Founder and President at Ziwig Biotech.
Stay updated on all scientific advances in the field of fertility with Fertility News.
-
Jul 29, 2026, 01:03Seeking a Second Opinion Is Not Being Difficult, It Is a Valid Part of Informed Care – PCOS Awareness Association
-
Jul 29, 2026, 00:57Szabo Gabor: IOTA Day 2026 Advancing Ultrasound in Gynaecological Oncology
-
Jul 29, 2026, 00:55Islam Badr: A Simple Approach to Fetal Heart Screening
-
Jul 29, 2026, 00:50Hardeep Singh: Understanding the Global IVF Travel Landscape
-
Jul 29, 2026, 00:48Asma Khatun: Shaping the Future of Women’s Healthcare at GFWH 2026
-
Jul 29, 2026, 00:43Shaping the Future of Reproductive Medicine at ASRM Innovate – ASRM
-
Jul 29, 2026, 00:37George Condous: Gratitude Makes Every Achievement Greater!
-
Jul 29, 2026, 00:35As AMH Falls, Progesterone May Rise Earlier in Ovarian Stimulation! – Fertility Plus
-
Jul 29, 2026, 00:33An Easy Method for Systematic Fetal Cardiac Screening – ISUOG